Page 8 - ஆண்டு உலகளாவிய சுகாதாரம் மாநாடு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Regeneron Announces Investor Conference Presentations News provided by Share this article REGN) will webcast management participation as follows: Bernstein s 37 Goldman Sachs 42 BMO Biopharma Day at 8:00 a.m. ET on Tuesday, June 22, 2021 The sessions may be accessed from the Investors & Media page of Regeneron s website at https://investor.regeneron.com/events-and-presentations.  Replays of the webcasts will be archived on the Company s website for at least 30 days. About  Regeneron Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye disease

Justin holkoPrnewswire regeneron pharmaceuticals incRegeneron pharmaceuticals incRegeneron genetics centerGoldman sachsAnnual strategic decisions conferenceAnnual global healthcare conferenceகோல்ட்மேன் சாக்ஸ்ஆண்டு மூலோபாய முடிவுகள் மாநாடுஆண்டு உலகளாவிய சுகாதாரம் மாநாடு